OMNIAB, INC. Increase (Decrease) in Accounts Receivable
OMNIAB, INC. (OABI) reported Increase (Decrease) in Accounts Receivable of $2.55 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsReceivable · last filed 2026-08-06
- OMNIAB, INC. increase (decrease) in accounts receivable for the quarter ending 2026-06-30 was -$2.37M.
- OMNIAB, INC. increase (decrease) in accounts receivable for the quarter ending 2026-03-31 was $4.92M, a 947.23% increase year-over-year.
- OMNIAB, INC. increase (decrease) in accounts receivable for the quarter ending 2025-12-31 was $2.18M, a 15.47% increase year-over-year.
- OMNIAB, INC. increase (decrease) in accounts receivable for the quarter ending 2025-09-30 was $230.00K.
- OMNIAB, INC. increase (decrease) in accounts receivable for fiscal 2025 was -$189.00K, a 130.24% decline from fiscal 2024.
- OMNIAB, INC. increase (decrease) in accounts receivable for fiscal 2024 was $625.00K.
- OMNIAB, INC. increase (decrease) in accounts receivable for fiscal 2023 was -$26.90M, a 311.18% decline from fiscal 2022.
- OMNIAB, INC. increase (decrease) in accounts receivable for fiscal 2022 was $12.74M.
| Period end | Increase (Decrease) in Accounts Receivable 3 month | Increase (Decrease) in Accounts Receivable 6 month | Increase (Decrease) in Accounts Receivable 9 month | Increase (Decrease) in Accounts Receivable 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$2.37M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $2.55M 10-Q · filed 2026-08-06 | $4.73M derived: sum of 3 quarters · filed 2026-08-06 | $4.96M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $4.92M 10-Q · filed 2026-05-07 | $7.10M derived: sum of 2 quarters · filed 2026-05-07 | $7.33M derived: sum of 3 quarters · filed 2026-05-07 | $4.26M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $2.18M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | $2.41M derived: sum of 2 quarters · filed 2026-03-04 | -$659.00K derived: sum of 3 quarters · filed 2026-08-06 | -$189.00K 10-K · filed 2026-03-04 |
| 2025-09-30 | $230.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$2.84M derived: sum of 2 quarters · filed 2026-08-06 | -$2.37M 10-Q · filed 2025-11-04 | -$481.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$3.07M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$2.60M 10-Q · filed 2026-08-06 | -$711.00K derived: sum of 3 quarters · filed 2026-08-06 | -$4.57M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $470.00K 10-Q · filed 2026-05-07 | $2.36M derived: sum of 2 quarters · filed 2026-05-07 | -$1.50M derived: sum of 3 quarters · filed 2026-05-07 | $1.23M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $1.89M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-04 | -$1.97M derived: sum of 2 quarters · filed 2026-03-04 | $757.00K derived: sum of 3 quarters · filed 2026-03-04 | $625.00K 10-K · filed 2026-03-04 |
| 2024-09-30 | -$3.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | -$1.13M derived: sum of 2 quarters · filed 2025-11-04 | -$1.26M 10-Q · filed 2025-11-04 | -$3.25M derived: sum of 4 quarters · filed 2025-11-04 |
| 2024-06-30 | $2.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $2.59M 10-Q · filed 2025-08-06 | $607.00K derived: sum of 3 quarters · filed 2025-08-06 | -$1.30M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$132.00K 10-Q · filed 2025-05-08 | -$2.12M derived: sum of 2 quarters · filed 2025-05-08 | -$4.02M derived: sum of 3 quarters · filed 2025-05-08 | $1.79M derived: sum of 4 quarters · filed 2025-05-08 |
| 2023-12-31 | -$1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-18 | -$3.89M derived: sum of 2 quarters · filed 2025-03-18 | $1.92M derived: sum of 3 quarters · filed 2025-03-18 | -$26.90M 10-K · filed 2025-03-18 |
| 2023-09-30 | -$1.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $3.91M derived: sum of 2 quarters · filed 2024-11-12 | -$24.91M 10-Q · filed 2024-11-12 | $5.44M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $5.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$23.01M 10-Q · filed 2024-08-08 | $7.34M derived: sum of 3 quarters · filed 2024-08-08 | $6.99M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$28.82M 10-Q · filed 2024-05-09 | $1.52M derived: sum of 2 quarters · filed 2024-05-09 | $1.17M derived: sum of 3 quarters · filed 2024-05-09 | $1.53M derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $30.35M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $29.99M derived: sum of 2 quarters · filed 2024-03-25 | $30.35M derived: sum of 3 quarters · filed 2024-03-25 | $12.74M 10-K · filed 2024-03-25 |
| 2022-09-30 | -$354.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.00K derived: sum of 2 quarters · filed 2023-11-09 | -$17.61M 10-Q · filed 2023-11-09 | |
| 2022-06-30 | $356.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10 | -$17.26M 10-Q · filed 2023-08-10 | ||
| 2022-03-31 | -$17.61M 10-Q · filed 2023-05-11 | |||
| 2021-12-31 | -$6.02M 10-K · filed 2023-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| OneMedNet Corp (ONMD) | $0.042B | ||
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |